A study by Elkoumi et al. in patients with pediatric-onset SLE (pSLE) reported that FCN2 promoter region polymorphisms may influence pSLE susceptibility, where rs3124952 and rs17514136 were significantly associated with increased risk of LN.14 This evidence concerns the gene FCN2 and systemic lupus erythematosus.